Abstract:Epigenetic gene regulations can be considered as de-novo initiation of abnormal molecular signaling events whose regulation is otherwise required during normal or specific developmental stages of the organisms. Primarily, three different mechanisms have been identified to participate in epigenetic gene regulations which include, DNA methylation, non-coding RNA species (microRNAs [miRNA], and long non-coding RNAs [LNC-RNA]) and histone modifications. These de-novo epigenetic mechanisms have been associated with altered normal cellular functions which eventually facilitate normal cells to transition into an abnormal phenotype. Among the three modes of regulation, RNA species which are usually considered to be less stable, can be speculated to initiate instant alterations in gene expression compared to DNA methylation or histone modifications. However, LNC-RNAs appear to be more stable in the cells than the other RNA species. Moreover, there is increasing literature which clearly suggests that a single specific LNC-RNA can regulate multiple mechanisms and disease phenotypes. With specific focus on cardiovascular diseases, here we attempt to provide UpToDate information on the functional role of miRNAs and LNC-RNAs. Here we discuss the role of these epigenetic mediators in different components of cardiovascular disease which include physiopathological heart development, athersclerosis, retenosis, diabetic hearts, myocardial infarction, ischemia-reperfusion, heart valve disease, aortic aneurysm, osteogenesis, angiogenesis and hypoxia in the heart. While there is abundant literature support that shows the involvement of many LNC-RNAs and miRNAs in cardiovascular diseases, very few RNA species have been identified which regulate epigenetic mechanisms which is the current focus in this article. Understanding the role of these RNA species in regulating epigenetic mechanisms in different cell types causing cardiovascular disease, would advance the field and promote disease prevention approaches that are aimed to target epigenetic mechanisms.

The Emerging Roles of Long Noncoding RNAs in Common Cardiovascular Diseases

The relationship between long non-coding RNA and cardiovascular development and diseases

Pathological Bases and Clinical Application of Long Noncoding RNAs in Cardiovascular Diseases

[Lncrnas and Cardiovascular Diseases].

The Roles of Long Noncoding RNAs in Myocardial Pathophysiology

Recent advances on the roles of LncRNAs in cardiovascular disease

The roles of long noncoding RNAs (lncRNAs) in myocardial pathophysiology.

Beyond the silence: A comprehensive exploration of long non-coding RNAs as genetic whispers and their essential regulatory functions in cardiovascular disorders

The roles of long noncoding RNA NEAT1 in cardiovascular diseases

Non-coding RNAs and angiogenesis in cardiovascular diseases: a comprehensive review

The regulation of circRNA and lncRNA protein binding in cardiovascular diseases: Emerging therapeutic targets

The Roles of lncRNA in Myocardial Infarction: Molecular Mechanisms, Diagnosis Biomarkers, and Therapeutic Perspectives

Long Noncoding RNA Discovery in Cardiovascular Disease: Decoding Form to Function

Extracellular Non-Coding RNAs in Cardiovascular Diseases

The Role of Long Non-Coding RNAs in Vascular Smooth Muscle Cell Phenotype and the Pathogenesis of Cardiovascular and Cerebrovascular Aneurysms

Long Non-coding RNA:Research Progress in Cardiac Disease

The functions of LncRNA in the heart

Non-coding RNAs as Epigenetic Gene Regulators in Cardiovascular Diseases

Research Progress in Action Mechanisms of Lncrnas in Vascular Diseases

Systematic Review Regulatory Principles of Non-Coding RNAs in Cardiovascular Diseases

Long noncoding RNAs as novel players in the pathogenesis of hypertension